Incidence and prognostic significance of disseminated tumor cells in patients with cervical carcinoma of the uterus;Inzidenz und prognostische signifikanz disseminierter tumorzellen bei patientinnen mit zervixkarzinom

Acta Medica Austriaca

Volumn 29, Issue SUPPL. 59, 2002, Pages 36-41

  Rack, Brigitte ^a,b,c   Janni, W ^a,b   Kentenich, C ^a,b   Strobl, B ^a,b   Klanner, E ^a,b   Schindlbeck, C ^a,b   Hepp, F ^a,b   Sommer, H ^a,b   Braun, S ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cervical carcinoma; Disseminated tumor cells; Incidence; Micrometastases; Prognosis

Indexed keywords

CYTOKERATIN; MARKER;

ARTICLE; BLOOD; BONE MARROW; BONE MARROW METASTASIS; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; DISSEMINATED CANCER; HUMAN; IMMUNOCYTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; MORBIDITY; PROGNOSIS; RECURRENT DISEASE; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0036959074     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kimmig R, K.R.H.C.L.H: Empfehlungen zur Diagnostik, Therapie und Nachsorge; Zervixkarzinom. 2002.
2. Levi F, Lucchini F, Negri E, La Vecchia C: The decline in cancer mortality in the European Union, 1988-1996. Eur J Cancer 2000;36:1965-1968.
3. Gerdin E, Cnattingius S, Johnson P, Pettersson B: Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy. Gynecol Oncol 1994;53:314-319.
4. Johnson DW, Cox RS, Billingham G, Ung N, Martinez A: Survival, prognostic factors, and relapse patterns in uterine cervical carcinoma. Am J Clin Oncol 1983;6:407-415.
5. Look KY, Rocereto TF: Relapse patterns in FIGO stage IB carcinoma of the cervix. Gynecol Oncol 1990;38:114-120.
6. Atasii T, Aksu MF, Cetinkaya MB: Prognostic factors that affect survival after the treatment of early stage cervical carcinoma. Int Surg 2000;85:147-151.
7. Chen RJ, Chang DY, Yen ML, Lee EF. Huang SC. Chow SN, Hsieh CY: Prognostic factors of primary adenocarcinoma of the uterine cervix. Gyneco. Oncol 1998;69:157-164.
8. Ishikawa H, Nakanishi T, Inoue T, Kuzuya K: Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol 1999;73:42-46.
9. Kapp KS, Stuecklschweiger GF, Kapp DS, Poschauko J, Pickel H. Lahousen M, Hackl A: Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1998;42:531-540.
10. Toita T, Nakano M, Higashi M, Sakumoto K, Kanazawa K: Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat. Oncol Biol Phys 1995;33, 843-849.
11. Trattner M, Graf AH, Lax S, Forstner R, Dandachi N, Haas J, Pickel H, Reich O, Staudach A, Winter R: Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol 2001;82:11-16.
12. DeEulis TG, Markoe AM, Sedlacek TV, Brady LW: The influence of hematogenous and serosal metastases on advanced (FIGO IIA-IVB) squamous cell carcinoma of the cervix. Am J Clin Oncol 1987;10:10-20.
13. Maassen V, Dieckhoff R, Baltzer J, Kindermann G: Über das Risiko der hamatogenen Fernmetastasierung beim Karzinom der Cervix uteri. Geburtshilfe Frauenheilkd 1994;54:656-661.
14. Komukai S, Nishimaki T Suzuki T, Kanda T, Kuwabara S, Hatakeyama K: Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma. Br J Surg 2002;89:213-219.
15. Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K: Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg 1997;114:339-346.
16. Gu CD, Osaki T, Oyama T, Inoue M, Kodate M, Dobashi K, Oka T, Yasumoto K: Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival. Ann Surg 2002;235:133-139.
17. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmuller G, Schlimok G: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525-533.
18. Braun S, Schindlbeck C, Hepp F, Janni W, Kentenich C, Riethmuller G, Pantel K: Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse. J Clin Oncol 2001;19:368-375.
19. Neumaier M, Gerhard M, Wagener C: Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 1995;159:43-47.
20. Ghossein RA, Bhattacharya S: Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer 2000;36:1681-1694.
21. Stenman J, Lintula S, Hotakainen K, Vartiainen J, Lehvaslaiho H, Stenman UH: Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix. Int J Cancer 1997;74:75-80.
22. Takeshima N, Suminami Y, Takeda O, Abe H, Okuno N, Kato H: Expression of mRNA of SCC antigen in squamous cells. Tumour Biol 1992;13:338-342.
23. Yuan CC, Wang PH, Ng HT, Li YF, Huang TS, Chen CY, Tsai LC, Shyong WY: Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation. Gynecol Oncol 2002;85:148-153.
24. Dong SM, Pai SI, Rha SH. Hildesheim A, Kurman RJ, Schwartz PE, Mortel R, McGowan L, Greenberg MD, Barnes WA, Sidransky D: Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prey 2002;11:3-6.
25. Czegledy J, Iosif C, Hansson BG, Evander M, Gergely L, Wadell G: Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer? Int J Cancer 1995;64, 211-215.
26. Pao CC, Hor JJ, Yang FP, Lin CY, Tseng CJ: Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J Clin Oncol 1997;5:1008-1012.
27. Czegledy J, Iosif C, Forslund O, Willen R, Hansson BG: Detection of human papilloma virus DNA in lymph nodes extirpated at radical surgery for cervical cancer is not predictive of recurrence. J Med Virol 1998;54:183-185.
28. Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, Weekes AR, Shepherd JH, Dorudi S, Bustin SA, Jacobs IJ: Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 2001;357:15-20.
29. Rack Bet al: Detection of disseminated tumor cells in the bone marrow of patients with cervical carcinoma of the uterus may predict patterns of reccurrence. ASCO Proc 2002 (Abstract).
30. Schabel FM Jr: Rationale for adjuvant chemotherapy. Cancer 1977;39:2875-2882.
31. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-786.
32. Hansgen G, Dunst J: Adjuvante Radio- und Chemotherapie beim Zervixkarzinom. Adjuvant radio- and chemotherapy in cervix carcinoma. Zentralbl Gynakol 2001;123:280-285.
33. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613.
34. Britten RA, Evans AJ, Allalunis-Turner MJ, Pearcey RG: Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Int J Radiat Oncol Biol Phys 1996;34:367-374.
35. Massi G, Savino L, Susini T: Schauta-Amreich vaginal hysterectomy and Wertheim-Meigs abdominal hysterectomy in the treatment of cervical cancer: a retrospective analysis. Am J Obstet Gynecol 1993;168:928-934.
36. Webb MJ, Symmonds RE: Wertheim hysterectomy: a reappraisal. Obstet Gynecol 1979;54:140-145.